Notably, to our knowledge, this is the first study to investigate the serum antiglycopeptidolipid core IgA antibody test and demonstrate its efficacy in a large cohort with bronchiectasis, although previous studies included a relatively small number of patients with bronchiectasis as a control group.15 Here, CD79A is linked to bronchiectasis.